Spots Global Cancer Trial Database for Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?
Official Title: Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?
Study ID: NCT03193008
Conditions
Interventions
Study Description
Brief Summary: AUS/FNAC allows the identification of tumors without axillary tumor involvement, or with low axillary tumor burden, many of which do not benefit from SLNB, in the staging of early breast cancer. Objective: To calculate the negative predictive value of AUS/FNAC in those patients with breast cancer who meet ACOSOG Z0011 criteria.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Javier del Riego, Sabadell, Barcelona, Spain
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
